Noncompartmental and compartmental modeling of the kinetics of carbon‐11 labeled pyrilamine in the human brain

The kinetic pattern of a 11C‐labeled histamine H1 receptor antagonist, [11C]pyrilamine, was investigated in the human brain by factor analysis of dynamic PET studies. Tissue time activity curves were also processed by compartment model curve fitting preceded by deconvolution analysis. Factor analysis revealed two statistically significant and physiologically meaningful kinetic patterns: one for specific and another for nonspecific binding of the radioligand. From these two factors a compartment model containing two tissue compartments (one for specific binding and another for nonspecific binding and free ligand) was constructed. The two‐compartment model was also supported by the impulse response function, which was obtained by deconvolution and showed two components. The factor image constructed from factor two demonstrated a distribution pattern characteristic for brain regions rich (frontal, parietal, and temporal lobes) or poor (occipital lobe and cerebellum) in H1 receptors. Blockade of H1 receptors with unlabeled pyrilamine, diphenhydramine, or hydroxyzine caused a significant reduction of this factor. Blockade produced no significant changes in factor one representing nonspecific binding.

[1]  H. N. Wagner,et al.  Multicompartmental Analysis of [11C]-Carfentanil Binding to Opiate Receptors in Humans Measured by Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[3]  Zsolt Szabo,et al.  Physiologic factor analysis (PFA) and parametric imaging of dynamic PET images , 1992, [1992] Proceedings Fifth Annual IEEE Symposium on Computer-Based Medical Systems.

[4]  D. Marquardt An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[5]  M. Jouvet,et al.  Evidence for histaminergic arousal mechanisms in the hypothalamus of cat , 1988, Neuropharmacology.

[6]  J. Tanaka,et al.  Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decar☐ylase as a marker , 1984, Brain Research.

[7]  W. G. Clark,et al.  Biphasic changes in body temperature produced by intracerebroventricular injections of histamine in the cat. , 1976, The Journal of physiology.

[8]  J. Schwartz,et al.  Chapter Nine – Histamine Receptors in the Brain and Their Possible Functions , 1982 .

[9]  A. Barnett,et al.  Pharmacology of non-sedating H1 antihistamines. , 1991, Agents and actions. Supplements.

[10]  J S Fowler,et al.  Kinetic Modeling of Receptor‐Ligand Binding Applied to Positron Emission Tomographic Studies with Neuroleptic Tracers , 1987, Journal of neurochemistry.

[11]  J C Mazziotta,et al.  A Double-Injection Technique for in vivo Measurement of Dopamine D2-Receptor Density in Monkeys with 3-(2'-[18F] Fluoroethyl)Spiperone and Dynamic Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  J. Schwartz,et al.  Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates , 1990, Brain Research.

[13]  J. P. Bazin,et al.  Handling of Dynamic Sequences in Nuclear Medicine , 1982, IEEE Transactions on Nuclear Science.

[14]  Alan A. Wilson,et al.  Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  T. K. Natarajan,et al.  Imaging histamine H1 receptors in the living human brain with carbon-11-pyrilamine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  S. Snyder,et al.  HETEROGENEITY OF HISTAMINE Hi‐RECEPTORS: SPECIES VARIATIONS IN [3H]MEPYRAMINE BINDING OF BRAIN MEMBRANES , 1979, Journal of neurochemistry.

[17]  L. Cinotti,et al.  Processing of Xe-127 regional pulmonary ventilation by factor analysis and compartmental modeling. , 1991, IEEE transactions on medical imaging.

[18]  L. Hough Cellular localization and possible functions for brain histamine: Recent progress , 1988, Progress in Neurobiology.

[19]  C. L. Olson On choosing a test statistic in multivariate analysis of variance. , 1976 .

[20]  J M Links,et al.  Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  K. B. Larson,et al.  Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  R E Carson,et al.  Precision and Accuracy Considerations of Physiological Quantitation in PET , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  K. Nagai,et al.  Changes in the feeding behavior of rats elicited by histamine infusion , 1988, Physiology & Behavior.